Real-world overall survival comparison between first-line Bruton tyrosine kinase inhibitors in treating chronic lymphocytic leukemia/small lymphocytic lymphoma: An analysis of Veterans Health Administration data. - Fitzgerald L; Ghosh S; Khan W; Bokun A; Lax A; Mu F; Cook EE; Chen J; Chen G; Wu E; Lin Y; Shi L; et al. (Journal of managed care & specialty pharmacy, 2026)